日期 | 时间 | 会场 | Session/主题 | 角色 | 姓名 | 单位 |
2019-11-09 | 11:30-11:45 | 2号楼岭南大会堂 | 全体大会2 Gilteritinib Significantly Prolongs Overall Survival in Patients With FLT3-Mutated (FLT3mut+) Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML): Results From the Phase 3 ADMIRAL Trial |
讲者 | Naoko Hosono | University of Fukui, Fukui, Japan |